InvestorsHub Logo
Followers 144
Posts 10941
Boards Moderated 0
Alias Born 04/02/2006

Re: None

Tuesday, 03/21/2017 1:55:12 PM

Tuesday, March 21, 2017 1:55:12 PM

Post# of 486
FWIW: I've emailed IR and asked about the timeline regarding the planned released of their technology.. Here's the answer I got:


Based on recent guidance, CVR Management has expectations of FDA approval by Q2 2018, therefore would be going commercial shortly thereafter. Time lines are difficult to predict based on all the moving parts : Tertiary trial results, then Pivotal Trials then FDA submission. Management is currently beginning tertiary trials at Jefferson.

Thankyou for the support


Scott Koyich

Investor Relations